F. Rizzo

发表

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

S. Salani, C. Donadoni, F. Rizzo, 2012, Journal of cellular and molecular medicine.

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons

S. Salani, F. Rizzo, N. Bresolin, 2019, Brain : a journal of neurology.

Animal Models of CMT2A: State-of-art and Therapeutic Implications

F. Rizzo, N. Bresolin, G. Comi, 2020, Molecular Neurobiology.

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model

S. Salani, F. Rizzo, N. Bresolin, 2013, Human molecular genetics.

Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype

F. Rizzo, N. Bresolin, G. Comi, 2016, Scientific Reports.

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1

S. Salani, F. Rizzo, N. Bresolin, 2014, Stem cell reports.

Clinical and genetic features of a cohort of patients with MFN2-related neuropathy

F. Rizzo, N. Bresolin, G. Comi, 2022, Scientific Reports.

Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art

F. Rizzo, N. Bresolin, G. Comi, 2019, Molecular Neurobiology.

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches

S. Salani, F. Rizzo, N. Bresolin, 2015, Scientific Reports.

Neural Stem Cell Transplantation for Neurodegenerative Diseases

F. Rizzo, N. Bresolin, G. Comi, 2020, International journal of molecular sciences.

Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

S. Salani, C. Donadoni, F. Rizzo, 2012, Science Translational Medicine.

Direct reprogramming of human astrocytes into neural stem cells and neurons

S. Salani, C. Donadoni, F. Rizzo, 2012, Experimental cell research.

Patients with Spinal Muscular Atrophy Genetic Correction of Human Induced Pluripotent Stem Cells from

S. Salani, C. Donadoni, F. Rizzo, 2012 .

Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons.

S. Salani, F. Rizzo, N. Bresolin, 2016, Human molecular genetics.

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin

S. Salani, F. Rizzo, N. Bresolin, 2017, Scientific Reports.

Synaptotagmin 13 is neuroprotective across motor neuron diseases

F. Rizzo, N. Bresolin, G. Comi, 2020, Acta Neuropathologica.

Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses

F. Rizzo, F. Grilli, R. Klima, 2018, Scientific Reports.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

S. Salani, F. Rizzo, S. Corti, 2013, Cellular and Molecular Life Sciences.

Efficacy of 12 weeks of proprioceptive training in patients with multiple sclerosis

F. Rizzo, G. Messina, P. Ragonese, 2019, Journal of Human Sport and Exercise - 2019 - Summer Conferences of Sports Science.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

S. Salani, F. Rizzo, S. Corti, 2013, Cellular and Molecular Life Sciences.

Mitochondrial Fusion Proteins and Human Diseases

F. Rizzo, N. Bresolin, G. Comi, 2013, Neurology research international.

Peptide-conjugated Morpholino Oligomers for treatment of Spinal Muscular Atrophy

F. Rizzo, N. Bresolin, G. Comi, 2016 .

F. Rizzo, N. Bresolin, G. Comi, 2015, Journal of the Neurological Sciences.

Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy Δ7 mouse model phenotype.

S. Salani, F. Rizzo, N. Bresolin, 2014, Clinical therapeutics.

Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis

F. Rizzo, N. Bresolin, S. Corti, 2011, Cellular and Molecular Life Sciences.

Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis

F. Rizzo, N. Bresolin, G. Comi, 2012, Cellular and Molecular Life Sciences.

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets

F. Rizzo, G. Comi, S. Corti, 2022, Biomedicines.

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model

S. Salani, F. Rizzo, N. Bresolin, 2015, Science Advances.

Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses

F. Rizzo, F. Grilli, R. Klima, 2018, Scientific Reports.

Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives

F. Rizzo, E. Abati, G. Comi, 2024, Neurobiology of Disease.

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A

S. Salani, F. Rizzo, S. Corti, 2023, Cellular and Molecular Life Sciences.

Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art

F. Rizzo, N. Bresolin, G. Comi, 2019, Molecular Neurobiology.

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons

S. Salani, F. Rizzo, N. Bresolin, 2019, Brain : a journal of neurology.